Pharmaceutical Economics & Health Policy
Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications

https://doi.org/10.1016/j.clinthera.2008.06.003Get rights and content

Abstract

Background: Rapid growth in prescription drug costs has compelled insurers to require increased patient cost-sharing.

Objective: The aim of this study was to compare the effects of 2 recent cost-sharing policies on emergency hospitalizations due to chronic obstructive pulmonary disease, asthma, or emphysema (CAE), and on physician visits.

Methods: We analyzed data from a large-scale natural experiment in British Columbia (BC), Canada. The cost-sharing policies were a fixed copayment policy (fixed copay policy) and an income-based deductible (IBD) policy with 25% coinsurance (IBD policy). Prescription, physician billing, and hospitalization records were obtained from the BC Ministry of Health. From the total population of BC residents ≥65 years of age, we extracted data from all patients dispensed an inhaled corticosteroid, β2-agonist, or anticholinergic from June 30, 1997, to April 30, 2004. Poisson regression was used to evaluate the impact of the policies in a cohort of patients receiving long-term inhaler treatment. An identically defined historical control group unaffected by the policy changes was used for comparison.

Results: The study population included 37,320 users of long-term inhaled medications from the BC population of 576,000 persons ≥65 years of age. During the IBD period but not the fixed copay period, emergency hospitalizations for CAE increased 41% (95% CI for adjusted rate ratio [RR], 1.24–1.60) in patients ≥65 years of age. There was also a significant increase in physician visits of 3% (95% CI for adjusted RR, 1.01–1.05). No significant increases were observed during the fixed copay period. In a secondary analysis using a concurrent control group, we estimated a smaller but significant increase in emergency CAE hospitalizations of 29% (95% CI for adjusted RR, 1.09–1.52). This analysis also showed increases in physician visits (fixed copay period RR, 1.03 [95% CI for adjusted RR, 1.01–1.05]; IBD period RR, 1.07 [95% CI for adjusted RR, 1.05–1.08]).

Conclusion: The results suggest that the IBD policy was likely associated with an increased risk for emergency hospitalization and physician visits in these users of inhaled medications who were aged ≥65 years.

References (32)

  • S Schneeweiss et al.

    Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers

    Clin Pharmacol Ther.

    (2003)
  • JK Marshall et al.

    Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia

    CMAJ.

    (2002)
  • S Schneeweiss et al.

    Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: Direct comparison of randomised and observational evaluations

    BMJ.

    (2004)
  • HA Huskamp et al.

    The effect of incentive-based formularies on prescription-drug utilization and spending

    N Engl J Med.

    (2003)
  • B Motheral et al.

    Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

    Med Care.

    (2001)
  • B Briesacher et al.

    Three-tieredcopayment drug coverage and use of nonsteroidal anti-inflammatory drugs

    Arch Intern Med.

    (2004)
  • Cited by (30)

    • Disparities in Disease Burden and Treatment of Patients Asthma and Chronic Obstructive Pulmonary Disease

      2022, Medical Clinics of North America
      Citation Excerpt :

      High-deductibles were also associated with higher ER and hospital utilization among those with COPD in one cross-sectional national US-based study.46 Another analysis similarly found an increase in admissions for airway disease after the introduction of higher drug cost-sharing in the province of British Columbia.50 While these sorts of cost-barriers may serve to reduce care for patients with COPD in general, they could contribute to disparities in lung health for 2 reasons.

    • Associations of health services utilization by prescription drug coverage and immigration category in Ontario, Canada

      2021, Health Policy
      Citation Excerpt :

      This variation results in coverage gaps for some Canadians, leaving them uninsured if they are ineligible for public drug plans, cannot afford private insurance and, if employed, do not have an employer-provided plan. In Canada, studies reveal that without timely access to prescribed medications, a disease may progress to an acute level resulting in an increased likelihood of adverse health outcomes and the use of more expensive secondary health services [16,58]. Migrant populations are more likely than those born in Canada to be uninsured for prescription drugs [27].

    • National Trends and Disparities in Health Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018

      2021, Chest
      Citation Excerpt :

      A 2018 statement from the American Thoracic Society outlined the harms to patients stemming from high pharmaceutical costs.25 Exposure to high out-of-pocket health care costs has been associated with less inhaler use26 and more hospitalizations among adults with obstructive lung disease3,14 and more ED visits15 and exacerbations13 among children with asthma. It seems likely that persistent gaps in coverage and health care access faced by lower-income and minority groups contribute to contemporary inequities in COPD and asthma outcomes.

    • Assessing the Effectiveness of Policies to Reduce Diabetes Hospitalizations Before and After the Reforms of Physician Payment and Primary Care Organization in British Columbia and Alberta

      2016, Canadian Journal of Diabetes
      Citation Excerpt :

      Most studies of PharmaCare suggest that the program had the potential to improve financial equity without affecting drug utilization significantly (31–33). However, 1 study that examined the potential effects on preventable hospitalizations of seniors associated the income-based deductible with higher emergency hospitalizations for seniors using inhaled medications for chronic pulmonary disease, asthma or emphysema (34). Alberta did not introduce any changes to its drug program during the period of the study (31).

    View all citing articles on Scopus
    View full text